Apr. 10 at 3:49 PM
$CRMD $ICUI $DVA $FMS
Defencath lowers by 70%+ per USRC RWE
Still interesting to see impact of devices in generals that could be used together… (ie Clearguard caps)
“A total of 2987 eligible hospitals (1288 Clave NCT, 1699 non-Clave NCT) with 17,452,575 central line-days were evaluated. All three Clave NCT hospital groups showed a statistically significant reduction in RR compared to the non-Clave NCT hospitals. The RR in Clave NCT hospitals was 0.93, a 7% decrease in CLABSI risk (p = 0.02). In the Clave NCT subgroups, mixed-use hospitals RR was 0.93, a 7% reduction (p = 0.04), while the Clave NCT high-volume hospitals experienced a 19% reduction, RR 0.81 (p = 0.04). An estimated 563 CLABSIs and 84 related deaths were avoided with use of Clave NCT and
$27,095,231 in cost savings.”
https://pubmed.ncbi.nlm.nih.gov/39097791/
